initial public offerings (IPOs) trading on American exchanges

Tuesday, October 9, 2018

BioXcel Therapeutics (BTAI) started trading on the Nasdaq on Thur 8 March 18

BioXcel Therapeutics Inc. (NASDAQ: BTAI) raised $60 million selling 5.5 million shares (upsized from 5 million) at $11 per share, the bottom of the expected range.

No comments:

Post a Comment